MCAP — MedCap AB (publ) Income Statement

0.000.00%

Last trade - 00:00

FinancialsSpeculativeMid CapNeutral

Annual income statement for MedCap AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	916	1,111	1,587	1,807	2,108
Cost of Revenue
Gross Profit	457	529	738	1,057	1,236
Selling / General / Administrative Expenses
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	789	940	1,360	1,534	1,805
Operating Profit	127	171	228	272	303
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	117	152	222	262	289
Provision for Income Taxes
Net Income After Taxes	98.1	118	173	209	221
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	96.5	118	172	207	220
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	96.5	118	172	207	220
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	6.52	8.07	12	14.4	14.5
Dividends per Share